Literature DB >> 11457357

Synthesis of enantioenriched axially chiral anilides from atropisomerically enriched tartarate ortho-anilides.

A Ates1, D P Curran.   

Abstract

Entities:  

Year:  2001        PMID： 11457357     DOI： 10.1021/ja010467p

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN： 0002-7863            Impact factor:   15.419


× No keyword cloud information.
  6 in total

1.  Remote, Late-Stage Oxidation of Aliphatic C-H Bonds in Amide-Containing Molecules.

Authors:  Takeshi Nanjo; Emilio C de Lucca; M Christina White
Journal:  J Am Chem Soc       Date:  2017-10-04       Impact factor: 15.419

2.  Rotational isomers of N-methyl-N-arylacetamides and their derived enolates: implications for asymmetric Hartwig oxindole cyclizations.

Authors:  Jérémie Mandel; Xiaohong Pan; E Ben Hay; Steven J Geib; Craig S Wilcox; Dennis P Curran
Journal:  J Org Chem       Date:  2013-04-09       Impact factor: 4.354

3.  Synthesis of highly enantioenriched 3,4-dihydroquinolin-2-ones by 6-exo-trig radical cyclizations of axially chiral alpha-halo-ortho-alkenyl anilides.

Authors:  David B Guthrie; Steven J Geib; Dennis P Curran
Journal:  J Am Chem Soc       Date:  2009-10-28       Impact factor: 15.419

4.  A Rhodium(I)-Xylyl-BINAP Catalyzed Asymmetric Ynamide-[2 + 2 + 2] Cycloaddition in the Synthesis of Optically Enriched N,O-Biaryls.

Authors:  Jossian Oppenheimer; Whitney L Johnson; Ruth Figueroa; Ryuji Hayashi; Richard P Hsung
Journal:  Tetrahedron       Date:  2009-06-27       Impact factor: 2.457

5.  (2R,3R)-1,4-Dioxa-spiro-[4.4]nonane-2,3-di-carb-oxy-lic and (2R,3R)-1,4-dioxa-spiro-[4.5]decane-2,3-di-carb-oxy-lic acids.

Authors:  Mikhail E Minyaev; Dmitrii M Roitershtein; Alexey A Vinogradov; Ivan V Ananyev; Ilya E Nifant'ev
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-07-06

Review 6.  Asymmetric Synthesis of Axially Chiral C-N Atropisomers.

Authors:  Patricia Rodríguez-Salamanca; Rosario Fernández; Valentín Hornillos; José M Lassaletta
Journal:  Chemistry       Date:  2022-03-25       Impact factor: 5.020
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.